Literature DB >> 24855508

Mesenchymal stem cells for treatment of myocardial infarction.

Il-Kwon Ko1, Byung-Soo Kim1.   

Abstract

Cardiovascular diseases including myocardial infarction are one of the major causes of adult mortality. Several treatments such as pharmacological therapy and heart transplantation have been used for the diseases, but the treatments have drawbacks. Therefore, cell-based myocardial therapies have received proper medical attention. Bone marrow stem cell (BMSC) including mesenchymal stem cell (MSC) and hematopoietic stem cell (HSC) is a potential source for cell therapy for heart diseases due to the ability of BMSC to differentiate into cell in cardiac tissue including cardiomyocyte and vascular endothelial cell. This article reviews the use of BMSCs for cardiovascular disease and the differentiation of BMSCs into cardiaomyocytes.

Entities:  

Keywords:  Cardiomyocyte; Differentiation; Mesenchymal stem cell; Myocardial infarction

Year:  2008        PMID： 24855508      PMCID： PMC4021775          DOI： 10.15283/ijsc.2008.1.1.49

Source DB:  PubMed          Journal:  Int J Stem Cells        ISSN： 2005-3606            Impact factor:   2.500


  32 in total

1.  Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.

Authors:  Hüseyin Ince; Michael Petzsch; Hans Dieter Kleine; Heike Eckard; Tim Rehders; Detlev Burska; Stephan Kische; Mathias Freund; Christoph A Nienaber
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

2.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Authors:  Massimiliano Gnecchi; Huamei He; Olin D Liang; Luis G Melo; Fulvio Morello; Hui Mu; Nicolas Noiseux; Lunan Zhang; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

3.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

Authors:  Eriko Tateishi-Yuyama; Hiroaki Matsubara; Toyoaki Murohara; Uichi Ikeda; Satoshi Shintani; Hiroya Masaki; Katsuya Amano; Yuji Kishimoto; Kohji Yoshimoto; Hidetoshi Akashi; Kazuyuki Shimada; Toshiji Iwasaka; Tsutomu Imaizumi
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

Review 4.  Adult bone marrow-derived stem cells for organ regeneration and repair.

Authors:  Florian Tögel; Christof Westenfelder
Journal:  Dev Dyn       Date:  2007-12       Impact factor: 3.780

5.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

6.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

Authors:  K A Jackson; S M Majka; H Wang; J Pocius; C J Hartley; M W Majesky; M L Entman; L H Michael; K K Hirschi; M A Goodell
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

7.  Sarcoma derived from cultured mesenchymal stem cells.

Authors:  Jakub Tolar; Alma J Nauta; Mark J Osborn; Angela Panoskaltsis Mortari; Ron T McElmurry; Scott Bell; Lily Xia; Ning Zhou; Megan Riddle; Tania M Schroeder; Jennifer J Westendorf; R Scott McIvor; Pancras C W Hogendoorn; Karoly Szuhai; Leann Oseth; Betsy Hirsch; Stephen R Yant; Mark A Kay; Alexandra Peister; Darwin J Prockop; Willem E Fibbe; Bruce R Blazar
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

8.  Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.

Authors:  Alma J Nauta; Geert Westerhuis; Alwine B Kruisselbrink; Ellie G A Lurvink; Roel Willemze; Willem E Fibbe
Journal:  Blood       Date:  2006-05-11       Impact factor: 22.113

9.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

10.  Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes.

Authors:  Uta Kunter; Song Rong; Peter Boor; Frank Eitner; Gerhard Müller-Newen; Zivka Djuric; Claudia R van Roeyen; Andrzej Konieczny; Tammo Ostendorf; Luigi Villa; Maja Milovanceva-Popovska; Dontscho Kerjaschki; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2007-04-25       Impact factor: 10.121
View more
  13 in total

Review 1.  Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease.

Authors:  Kyung-Bok Lee; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 2.  Somatic cell dedifferentiation/reprogramming for regenerative medicine.

Authors:  Thiyagarajan Ramesh; Sun-Hee Lee; Choon-Soo Lee; Yoo-Wook Kwon; Hyun-Jai Cho
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

3.  Mesenchymal Stem Cells and Mononuclear Cells From Cord Blood: Cotransplantation Provides a Better Effect in Treating Myocardial Infarction.

Authors:  Gecai Chen; Aihuan Yue; Hong Yu; Zhongbao Ruan; Yigang Yin; Ruzhu Wang; Yin Ren; Li Zhu
Journal:  Stem Cells Transl Med       Date:  2016-01-21       Impact factor: 6.940

4.  Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR-9 pathway.

Authors:  Weidong Bing; Xinyan Pang; Qingxi Qu; Xiao Bai; Wenwen Yang; Yanwen Bi; Xiaolu Bi
Journal:  J Cell Mol Med       Date:  2016-02-12       Impact factor: 5.310

Review 5.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

Review 6.  How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?

Authors:  Liangpeng Li; Xiongwen Chen; Wei Eric Wang; Chunyu Zeng
Journal:  Stem Cells Int       Date:  2015-11-22       Impact factor: 5.443

7.  Delivery of biotinylated IGF-1 with biotinylated self-assembling peptides combined with bone marrow stem cell transplantation promotes cell therapy for myocardial infarction.

Authors:  Ming Zhang; Wen-Wei Ai; Zhi-Liang Mei; Yun-Hua Hu; Zhi-Ling Zhang
Journal:  Exp Ther Med       Date:  2017-08-21       Impact factor: 2.447

8.  A pH probe inhibits senescence in mesenchymal stem cells.

Authors:  Lihong Wang; Xianjing Han; Guojing Qu; Le Su; Baoxiang Zhao; Junying Miao
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

9.  Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.

Authors:  Guo-wen Hu; Qing Li; Xin Niu; Bin Hu; Juan Liu; Shu-min Zhou; Shang-chun Guo; Hai-li Lang; Chang-qing Zhang; Yang Wang; Zhi-feng Deng
Journal:  Stem Cell Res Ther       Date:  2015-04-10       Impact factor: 6.832

10.  Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin.

Authors:  Senthilkumar Kalimuthu; Liya Zhu; Ji Min Oh; Prakash Gangadaran; Ho Won Lee; Se Hwan Baek; Ramya Lakshmi Rajendran; Arunnehru Gopal; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Int J Med Sci       Date:  2018-06-22       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.